Violet Defense Offers Affordable Disinfection as a Service to Respond to COVID-19 Surges

UV disinfection products safely kill COVID-19, flu, and Norovirus to protect people, industries, and the environment

Violet Defense notes as the Omicron coronavirus variant sweeps the country and COVID-19 cases surge, many businesses are trying to ride it out with standard or even diminished precautions.

Violet Defense, a UV disinfection technology company, provides a better, sustainable, and long-term solution that is now available as a service.

Violet Defense is the developer of patented ultraviolet (UV) light technology proven in laboratory tests to kill bacteria and viruses, including coronavirus, norovirus, E. coli, C. diff, C. auris, Salmonella and MRSA. Its pulsed Xenon solution can be permanently installed or used in portable units.

Public-serving organizations are trying to remain open during the latest coronavirus resurgence, using standard chemical disinfection methods that have been insufficient and put workers at risk. Meanwhile, employees and customers are less often using precautions like social distancing and masks. That translates to increased risk of infection.

“The rapid spread of the latest COVID-19 variant has shown clearly that we don’t have the proper protections in place,” said Violet Defense CEO Terrance Berland. “Superior disinfection practices are not a luxury to aspire to anymore, they are a necessity, and UV disinfection is a proven way to keep people safe.”

Schools, hospitals, and all types of businesses are struggling to stay open as large numbers of employees become ill and quarantine. Even after the coronavirus pandemic subsides, illnesses like influenza will pose the same problem. That reminds us that vaccination, rapid testing and contact tracing alone cannot keep the public safe – frequent, thorough and effective disinfection is also vital.

With that in mind, Violet Defense is developing a new business model, Disinfection as a Service, where businesses can install its UV disinfection products via a lease-style arrangement, making it an operating expense instead of a capital purchase. The small Violet Defense unit would cost little more than $1 per disinfection cycle.

“We have a responsibility to protect our children, first responders, teachers, business owners – everyone. In that sense, disinfection is essentially a public service,” Berland said. “With Violet Defense’s new program, it’s an easy choice to get the best disinfection possible – at little more than $1 per disinfection cycle, how can you afford not to?”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The ArthroFree system is the first FDA-cleared wireless camera for arthroscopy and general endoscopy, both areas of minimally invasive surgery. The system is designed to help surgeons work with aximum dexterity and focus.
The project, which was led by the University of Southern California, included large increases in representation among men of African, Hispanic and Asian ancestries, that were contributed in part by an ongoing collaboration between the U.S. Department of Veterans Affairs and DOE reports Argonne.
This innovative software turns smartphones into medical-grade stethoscopes, allowing people to capture, analyze, and share critical heart health data with medical personnel from the comfort of any location notes Sparrow BioAcoustics.
"Taewoong Medical becoming an Olympus group company is also a major milestone in our global growth strategy," said Henry Shin, CEO of STARmed. "We look forward to our products being made available to more patients through Olympus' global distribution network."
The company reports they have successfully met the six-month primary endpoint for the first-ever female patient implanted with the UroActive™ System, the first smart automated artificial urinary sphincter (AUS) to treat SUI.

By using this website you agree to accept Medical Device News Magazine Privacy Policy